Foresite Capital is a healthcare firm that was incepted in the year 2011 with the aim of scaling the heights of innovation in the health sector and enhancement of patient care. It is through their unrelenting efforts to achieve their strategic mission and vision that they sought to collaborate with Dr. Molly He, Ph.D. as their business partner on 24th April, 2017.
Dr. Molly’s Qualifications
She studied at the University of California, Los Angeles, has published twenty journal articles. From the year 2007 to 2009, she served as the head of Protein Sciences in Pacific Biosciences and managed to oversee scientific professionals and a technical team in various research programs. She is remembered for her ability to amicably solve conflicts that arose in the team and worked towards manufacturing and developing a pilot production and learn more about Jim.
In the year 2002 to 2007, the renowned scientist worked as the project leader and senior scientist at Sunesis Pharmaceuticals. Here, she was not any different in her exemplary performance. She coalesced with a group of leading scientists in drugs discovery.
From the year 2000 to 2002, she worked as a researcher in Protein Structural Biology and Molecular Interactions in Chiron. The two years played a significant role in building her foundation and more information click here.
What does Foresite Capital stand to gain?
Dr. Molly’s outstanding qualifications and expertise are a great asset to the firm as they are an assurance of sustainable growth. Foresite Capital is still a young company that is at the peak of its growth, and such kind of an investment is what it needs to ensure that it does not decline.
If the remarks given by the chief executive officer, Jim Tananbaum are anything to go by, then the business is on the right track. He owed this to the fact that the vision and mission of the company are aligned to Dr. Molly’s expertise.
Dr. Molly was equally glad to be a part of the firm and vowed to work tirelessly to help the firm grow to greater heights and Jim of Twitter.
About Jim Tananbaum
Dr. Jim Tananbaum is not only a proficient medic but also a businessperson and an entrepreneur. Having acquired an M.B.A from Harvard Business School and an M.D from Harvard Medical School, he is well equipped to venture into many fields.
He has served as a manager at GelTex Pharmaceuticals and Amira Pharmaceuticals. The entrepreneur has also founded his companies namely Prospect Venture Partners, Theravance and Foresite Capital Management which is the most recent one.